A\u015f\u0131lar\u0131n ara\u015ft\u0131r\u0131lmaya ba\u015fland\u0131\u011f\u0131 s\u00fcre\u00e7ten bu g\u00fcne g\u00fc\u00e7l\u00fc seyahati<\/strong><\/p>\n

Pfizer\/ BioNTech<\/strong><\/p>\n

Almanya’da T\u00fcrk bilim insan\u0131 Prof. Dr. U\u011fur \u015eahin’in kurucu orta\u011f\u0131 oldu\u011fu biyoteknoloji firmas\u0131 BioNTech’in geli\u015ftirdi\u011fi “BNT162b1” ismi verilen a\u015f\u0131 aday\u0131, 3’\u00fcnc\u00fc etap denemelere ba\u015flayan birinci a\u015f\u0131 adaylar\u0131ndan biri oldu.<\/p>\n

ABD’de Pfizer, \u00c7in’de Fosun Pharma ila\u00e7 firmalar\u0131n\u0131n \u00fcretim lisans\u0131n\u0131 ald\u0131\u011f\u0131 a\u015f\u0131 aday\u0131 i\u00e7in 1’nci ve 2’nci evre klinik denemelerinin Almanya\u2019da y\u00fcr\u00fct\u00fclmesinin akabinde 27 Temmuz\u2019da ABD, Arjantin ve Almanya\u2019n\u0131n ortalar\u0131nda oldu\u011fu \u00fclkelerde 30 bin sa\u011fl\u0131kl\u0131 g\u00f6n\u00fcll\u00fcn\u00fcn kat\u0131lmas\u0131 amac\u0131yla 3. basamak klinik denemeler ba\u015flat\u0131ld\u0131.<\/p>\n

AB’nin Kas\u0131m ay\u0131 ortalar\u0131nda Pfizer ve BioNTech’in Kovid-19 vir\u00fcs\u00fcne kar\u015f\u0131 geli\u015ftirmekte oldu\u011fu a\u015f\u0131dan 300 milyon doz al\u0131m\u0131n\u0131 sa\u011flayacak mukaveleye onay verdi\u011fi a\u00e7\u0131kland\u0131.<\/p>\n

18 Kas\u0131m 2020 tarihinde, Pfizer Kovid-19\u2019a kar\u015f\u0131 geli\u015ftirilen a\u015f\u0131n\u0131n y\u00fczde 95 aktiflik g\u00f6sterdi\u011fini duyurdu.<\/p>\n

ABD S\u0131hhat Bakan\u0131 Alex Azar, Kas\u0131m ay\u0131 sonunda BioNTech’in Amerikan ila\u00e7 \u015firketi Pfizer ile geli\u015ftirdi\u011fi Kovid-19 a\u015f\u0131s\u0131n\u0131n y\u0131lba\u015f\u0131ndan evvel da\u011f\u0131t\u0131m\u0131na ba\u015flanaca\u011f\u0131n\u0131 a\u00e7\u0131klad\u0131.<\/p>\n

2 Aral\u0131k 2020 tarihinde ise, \u0130ngiltere’de yayg\u0131n kullan\u0131m\u0131na m\u00fcsaade verilen, BioNTech ve Pfizer\u2019\u0131n geli\u015ftirdi\u011fi a\u015f\u0131s\u0131n\u0131n gelecek hafta uygulanmaya ba\u015flanaca\u011f\u0131 bildirildi.<\/p>\n

Moderna<\/strong><\/p>\n

ABD’de “Moderna” ila\u00e7 firmas\u0131n\u0131n Ulusal Alerji ve Bula\u015f\u0131c\u0131 Hastal\u0131klar Enstit\u00fcs\u00fc i\u015f birli\u011fiyle geli\u015ftirdi\u011fi a\u015f\u0131 aday\u0131 “mRNA-1273”, FDA’n\u0131n onay vermesinin akabinde a\u015f\u0131n\u0131n 1’inci etap klinik denemeleri, 17 Mart’ta Washington eyaletinde ba\u015flad\u0131. mRNA-1273, “insanlar \u00fczerinde denenmeye ba\u015flanan birinci potansiyel Kovid-19 a\u015f\u0131s\u0131” oldu.<\/p>\n

A\u015f\u0131 aday\u0131n\u0131n 3’\u00fcnc\u00fc evre klinik denemeleri ABD\u2019de 38 merkezde s\u00fcrd\u00fcr\u00fcld\u00fc ve denemeye 30 bin istekli kat\u0131ld\u0131.<\/p>\n

ABD Lideri Trump, A\u011fustos ay\u0131nda 100 milyon dozluk Kovid-19 a\u015f\u0131s\u0131n\u0131n \u00fcretimi ve teslimi i\u00e7in Moderna ile mutabakat yap\u0131ld\u0131\u011f\u0131n\u0131 duyurdu.<\/p>\n

\u015eirket 16 Kas\u0131m’da yapt\u0131\u011f\u0131 a\u00e7\u0131klamada, s\u00fcren \u00e7al\u0131\u015fmadan elde edilen birinci bilginin a\u015f\u0131 aday\u0131n\u0131n y\u00fczde 95,4 tesirli oldu\u011funu ortaya koydu\u011funu bildirdi.<\/p>\n

AB, Kas\u0131m ay\u0131 sonuna hakikat yapt\u0131\u011f\u0131 a\u00e7\u0131klamada, Moderna firmas\u0131n\u0131n Kovid-19\u2019a kar\u015f\u0131 geli\u015ftirmekte oldu\u011fu a\u015f\u0131dan 160 milyon doz al\u0131m sa\u011flayacak kontrata onay verdiklerini duyurdu.<\/p>\n

\u00c7abucak akabinde, ABD S\u0131hhat Bakan\u0131 Alex Azar, Moderna\u2019n\u0131n geli\u015ftirdi\u011fi a\u015f\u0131n\u0131n y\u0131l sonuna kadar da\u011f\u0131t\u0131m\u0131na ba\u015flanaca\u011f\u0131n\u0131 a\u00e7\u0131klad\u0131.<\/p>\n

AstraZeneca- Oxford Universitesi<\/strong><\/p>\n

\u0130ngiltere’de Oxford \u00dcniversitesi Jenner Enstit\u00fcs\u00fc ile Oxford A\u015f\u0131 K\u00fcmesi i\u015f birli\u011finde geli\u015ftirilen ve \u00fcretim lisans\u0131 \u0130ngiliz-\u0130sve\u00e7 ila\u00e7 \u015firketi AstraZeneca taraf\u0131ndan sat\u0131n al\u0131nan a\u015f\u0131 aday\u0131 “AZD1222” i\u00e7in, \u0130ngiltere ve Hindistan\u2019da 2’nci ve 3’\u00fcnc\u00fc evre, Brezilya, G\u00fcney Afrika ve ABD\u2019de 3’\u00fcnc\u00fc kademe klinik denemeler y\u00fcr\u00fct\u00fcld\u00fc.<\/p>\n

ABD idaresinin May\u0131s ay\u0131nda yapt\u0131\u011f\u0131 a\u00e7\u0131klamaya nazaran, ABD’nin AstraZeneca PLC’ye 1,2 milyar dolar \u00f6deme yapaca\u011f\u0131 ve bunun kar\u015f\u0131l\u0131\u011f\u0131nda birinci etapta ABD’de 30 bin \u015fahsa a\u015f\u0131 testi yap\u0131lmas\u0131, \u00fcretim kapasitesinin de en az 300 milyon doza \u00e7\u0131kar\u0131lmas\u0131n\u0131n istendi\u011fi duyuruldu.<\/p>\n

AB Kurulu A\u011fustos ay\u0131nda Kovid-19’a kar\u015f\u0131 geli\u015ftirilen muhtemel a\u015f\u0131 \u00f6n al\u0131m stratejisi kapsam\u0131nda, birinci mutabakat\u0131n merkezi \u0130ngiltere’nin Cambridge kentinde olan ila\u00e7 firmas\u0131 AstraZeneca ile yap\u0131ld\u0131\u011f\u0131n\u0131 a\u00e7\u0131klad\u0131. Geli\u015ftirilen a\u015f\u0131n\u0131n Kovid-19’a kar\u015f\u0131 inan\u00e7l\u0131 ve tesirli oldu\u011funun kan\u0131tlanmas\u0131n\u0131n akabinde AB \u00fcyesi \u00fclkeler ismine 300 milyon doz al\u0131naca\u011f\u0131 belirtilen a\u00e7\u0131klamada, yap\u0131lan mukavelede 100 milyon doz ek a\u015f\u0131 al\u0131m\u0131 se\u00e7ene\u011finin de yer ald\u0131\u011f\u0131 kaydedildi.<\/p>\n

\u0130la\u00e7 firmas\u0131, bir g\u00f6n\u00fcll\u00fcde ortaya \u00e7\u0131kan hastal\u0131k nedeniyle bir m\u00fcddet \u00e7al\u0131\u015fmalar\u0131n\u0131 ask\u0131ya ald\u0131. Lakin Eyl\u00fcl ay\u0131nda \u00e7al\u0131\u015fmalar\u0131n tekrar devam edilmesine karar verdi.<\/p>\n

23 Kas\u0131m\u2019da Oxford \u00dcniversitesi\u2019nden yap\u0131lan a\u00e7\u0131klamaya nazaran, devam eden \u00e7al\u0131\u015fmalardan elde edilen datalar, a\u015f\u0131s\u0131n\u0131n y\u00fczde 70 tesirli oldu\u011funu ortaya koydu.<\/p>\n

Johnson<\/strong> and Johnson <\/strong><\/p>\n

Amerikan ila\u00e7 firmas\u0131 Johnson & Johnson’\u0131n ba\u011fl\u0131 i\u015ftiraki Bel\u00e7ikal\u0131 Janssen ila\u00e7 \u015firketi de a\u015f\u0131 aday\u0131 “Ad26COVS1” i\u00e7in 15 Temmuz\u2019da Bel\u00e7ika ve ABD\u2019de ba\u015flad\u0131\u011f\u0131 klinik denemeleri 3. kademeye ta\u015f\u0131d\u0131.<\/p>\n

ABD h\u00fck\u00fcmeti A\u011fustos ay\u0131nda, Johnson & Johnson (J&J) ile 100 milyon dozluk Kovid-19 a\u015f\u0131s\u0131n\u0131n \u00fcretimi ve teslimi i\u00e7in 1 milyar dolarl\u0131k mutabakat ger\u00e7ekle\u015ftirdi.<\/p>\n

J&J firmas\u0131 Ekim ay\u0131nda bir i\u015ftirak\u00e7inin hastalanmas\u0131 nedeniyle Kovid-19 a\u015f\u0131 denemesine orta verdi, ama a\u015f\u0131 \u00e7al\u0131\u015fmalar\u0131 k\u0131sa bir m\u00fchlet sonra tekrar devam etti.<\/p>\n

AB Kas\u0131m ay\u0131 ortas\u0131nda, J&J \u015firketiyle 400 milyon doza kadar a\u015f\u0131 almak i\u00e7in anla\u015ft\u0131\u011f\u0131n\u0131 a\u00e7\u0131klad\u0131.<\/p>\n

Novavax<\/strong><\/p>\n

ABD’li ila\u00e7 firmas\u0131 Novavax’\u0131n a\u015f\u0131 aday\u0131 “NVX-CoV2373” de 3’\u00fcnc\u00fc etap denemelere ba\u015flayan potansiyel Kovid-19 a\u015f\u0131lar\u0131 ortas\u0131nda yer ald\u0131.<\/p>\n

ABD h\u00fck\u00fcmeti Temmuz ay\u0131nda, Maryland eyaletinde faaliyet g\u00f6steren \u015firkete, gelecek y\u0131l\u0131n ba\u015f\u0131nda 100 milyon doz Kovid-19 a\u015f\u0131s\u0131 \u00fcretmesi halinde 1,6 milyar dolar \u00f6demeyi taahh\u00fct etti. \u015eirket ayr\u0131yeten Avustralya h\u00fck\u00fcmetiyle 30 milyon doz a\u015f\u0131 sa\u011flamak \u00fczere mutabakata vard\u0131.<\/p>\n

Hindistan Serum Enstit\u00fcs\u00fc (SII) ile imalat muahedesi imzalayan \u015firket y\u0131lda 2 milyar doz a\u015f\u0131 \u00fcretmeyi hedefledi\u011fini duyurdu.<\/p>\n

Sinovac<\/strong><\/p>\n

Sinopharm, Sinovac ve CanSino \u00fczere kamuya ili\u015fkin ila\u00e7 firmalar\u0131, \u00c7in Askeri T\u0131p Akademisi, Vuhan Viroloji Enstit\u00fcs\u00fc, Pekin Biyolojik Eserler Enstit\u00fcs\u00fc \u00fczere kurumlarla i\u015f birli\u011fi i\u00e7inde a\u015f\u0131 \u00e7al\u0131\u015fmalar\u0131 y\u00fcr\u00fct\u00fcyor.<\/p>\n

SinoVac’\u0131n geli\u015ftirdi\u011fi “CoronaVac”, Sinopharm’\u0131n Vuhan Viroloji Enstit\u00fcs\u00fc ve Pekin Biyolojik Eserler Enstit\u00fcs\u00fc ile geli\u015ftirdi\u011fi 2 a\u015f\u0131 aday\u0131 ile CanSino’nun \u00c7in Askeri T\u0131p Akademisi ile i\u015f birli\u011finde geli\u015ftirdi\u011fi “Ad5-NCov” isimli a\u015f\u0131 aday\u0131 umut ba\u011flanan \u00e7al\u0131\u015fmalar ortas\u0131nda g\u00f6r\u00fcl\u00fcyor.<\/p>\n

S\u0131hhat Bakan\u0131 Fahrettin Koca, Aral\u0131k ba\u015f\u0131nda Sinovac\u2019\u0131n geli\u015ftirdi\u011fi a\u015f\u0131 hakk\u0131nda “A\u015f\u0131yla ilgili olarak, Aral\u0131k ay\u0131nda a\u011f\u0131r bir halde ba\u015flamak istiyoruz. Bununla ilgili inaktif dedi\u011fimiz, daha evvelden teknik olarak iyi bildi\u011fimiz, yan tesirinin de az oldu\u011funu d\u00fc\u015f\u00fcnd\u00fc\u011f\u00fcm\u00fcz a\u015f\u0131dan 50 milyon kontrat imzaland\u0131.\u201d a\u00e7\u0131klamas\u0131n\u0131 yapt\u0131.<\/p>\n<\/p>\n

Bloomberg HT<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"

2019 y\u0131l\u0131 Aral\u0131k ay\u0131ndan bu yana d\u00fcnyay\u0131 tesiri alt\u0131na alan Kovid-19 salg\u0131n\u0131, bir y\u0131l\u0131n akabinde yakla\u015f\u0131k olarak 65 milyon ki\u015finin hastalanmas\u0131na …<\/p>\n","protected":false},"author":1,"featured_media":16083,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[46,196,1976,1477,405],"class_list":["post-16082","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ekonomi","tag-abd","tag-asi","tag-asi-adayi","tag-kasim","tag-ulkeler"],"yoast_head":"\n